|
LuTran Pharmaceuticals
|
|
LuTran is a pharmaceutical research company headquartered in Silicon Valley with the objective of discovering and developing novel medicines for debilitating viral and neurological diseases: from AIDS through biosafety level 4 viruses, including Ebola hemorrhagic fever and Alzheimer’s. History LuTran was founded in 2016 and is directed by Ronald Griffith, Ph.D., the company’s Director and Chief Science Officer. He is a senior executive with over 30 years of experience in the complete drug development process with a focus on virology and neurological diseases. Ronald has published over 150 patents and publications. LuTran has multiple compounds in development against the viruses of HIV/AIDS, Ebola, RSV, VZV and . Drug discovery efforts focus on improving intrinsic potency through stronger hydrophobic synergies in the target receptor, consequently improving efficacy and enhancing safety through maximizing specific hydrophobic interactions. See Also
|
| < Prev | Next > |
|---|
Main Menu
| Home |
| Articles |
| Search |
| Submit Article |
| Contact Us |
| Donate to Wikibin |
